Outcomes of allogeneic hematopoietic stem cell transplantation in Shwachman-Diamond syndrome: a systematic review and meta-analysis
Authors:
- 17 December 2024
- journal article
- review article
- Published by Elsevier in Cytotherapy
- Vol. 27 (4) , 465-474
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Beneficial effects of cellular immunotherapy in the prevention and treatment of posttransplant hematologic relapse of myelodysplastic neoplasmsAnnals of Hematology, 2024
- Myeloablative Versus Reduced-Intensity Conditioning With Fludarabine/Busulfan for Myelodysplastic Syndrome: A Propensity Score-Matched AnalysisTransplantation and Cellular Therapy, 2022
- Shwachman‐Diamond syndrome and solid tumors: Three new patients from the French Registry for Severe Chronic Neutropenia and literature reviewPediatric Blood & Cancer, 2021
- Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research StudyTransplantation and Cellular Therapy, 2020
- Hematopoietic Stem Cell Transplantation for Shwachman-Diamond SyndromeTransplantation and Cellular Therapy, 2020
- A Prospective Study of Hematologic Complications and Long-Term Survival of Italian Patients Affected by Shwachman-Diamond SyndromeThe Journal of Pediatrics, 2020
- Diagnosis, Treatment, and Molecular Pathology of Shwachman-Diamond SyndromeHematology/Oncology Clinics of North America, 2018
- Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure DisordersTransplantation and Cellular Therapy, 2017
- Treosulfan-Based Conditioning and Hematopoietic Cell Transplantation for Nonmalignant Diseases: A Prospective Multicenter TrialTransplantation and Cellular Therapy, 2014
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986